TCL Archive Advisors to NCI are preparing to recommend a “Human Cancer Genome Project” that would create a comprehensive chart of the genetic mutations that cause cancer. The panel also plans to propose an initiative in molecular diagnostics, Eric Lander, director of the Broad Institute, said. September 17, 2004
TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005
TCL Archive In Brief: FDA Commissioner Kessler Named Dean, Yale Medical School, Effective July 1 February 21, 1997
TCL Archive CALGB Grant OKed, But Group May Lose Support For Its Non-Hematologic Segments January 8, 1982
